BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20597012)

  • 1. Refinement of the hamster model of Clostridium difficile disease.
    Douce G; Goulding D
    Methods Mol Biol; 2010; 646():215-27. PubMed ID: 20597012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small animal models for the study of Clostridium difficile disease pathogenesis.
    Hutton ML; Mackin KE; Chakravorty A; Lyras D
    FEMS Microbiol Lett; 2014 Mar; 352(2):140-9. PubMed ID: 24372713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive profiles of infection and pathology in hamsters infected with Clostridium difficile strains 630 and B1.
    Goulding D; Thompson H; Emerson J; Fairweather NF; Dougan G; Douce GR
    Infect Immun; 2009 Dec; 77(12):5478-85. PubMed ID: 19752031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of a mixture of kefir-isolated lactic acid bacteria and yeasts in a hamster model of Clostridium difficile infection.
    Bolla PA; Carasi P; Bolla Mde L; De Antoni GL; Serradell Mde L
    Anaerobe; 2013 Jun; 21():28-33. PubMed ID: 23542116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive immunisation of hamsters against Clostridium difficile infection using antibodies to surface layer proteins.
    O'Brien JB; McCabe MS; Athié-Morales V; McDonald GS; Ní Eidhin DB; Kelleher DP
    FEMS Microbiol Lett; 2005 May; 246(2):199-205. PubMed ID: 15899406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection of hamsters with historical and epidemic BI types of Clostridium difficile.
    Razaq N; Sambol S; Nagaro K; Zukowski W; Cheknis A; Johnson S; Gerding DN
    J Infect Dis; 2007 Dec; 196(12):1813-9. PubMed ID: 18190262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OG716: Designing a fit-for-purpose lantibiotic for the treatment of Clostridium difficile infections.
    Kers JA; DeFusco AW; Park JH; Xu J; Pulse ME; Weiss WJ; Handfield M
    PLoS One; 2018; 13(6):e0197467. PubMed ID: 29894469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile.
    Mathur T; Kumar M; Barman TK; Kumar GR; Kalia V; Singhal S; Raj VS; Upadhyay DJ; Das B; Bhatnagar PK
    J Antimicrob Chemother; 2011 May; 66(5):1087-95. PubMed ID: 21393140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization of hamsters against Clostridium difficile infection using the Cwp84 protease as an antigen.
    Péchiné S; Denève C; Le Monnier A; Hoys S; Janoir C; Collignon A
    FEMS Immunol Med Microbiol; 2011 Oct; 63(1):73-81. PubMed ID: 21707776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro and in-vivo characterisation of resistance to colonisation with Clostridium difficile.
    Larson HE; Welch A
    J Med Microbiol; 1993 Feb; 38(2):103-8. PubMed ID: 8429534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridial typhlitis associated with topical antibiotic therapy in a Syrian hamster.
    Alworth L; Simmons J; Franklin C; Fish R
    Lab Anim; 2009 Jul; 43(3):304-9. PubMed ID: 19116288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection of hamsters with epidemiologically important strains of Clostridium difficile.
    Sambol SP; Tang JK; Merrigan MM; Johnson S; Gerding DN
    J Infect Dis; 2001 Jun; 183(12):1760-6. PubMed ID: 11372028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for working with the mouse model.
    Collignon A
    Methods Mol Biol; 2010; 646():229-37. PubMed ID: 20597013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile and the disease it causes.
    Norén T
    Methods Mol Biol; 2010; 646():9-35. PubMed ID: 20597000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Clostridium difficile in hospitalised patients with acute diarrhoea in Calcutta.
    Niyogi SK; Bhattacharya SK; Dutta P; Naik TN; De SP; Sen D; Saha MR; Datta D; Nair GB; Mitra U
    J Diarrhoeal Dis Res; 1991 Mar; 9(1):16-9. PubMed ID: 1869797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile enteritis: a review and pooled analysis of the cases.
    Kim JH; Muder RR
    Anaerobe; 2011 Apr; 17(2):52-5. PubMed ID: 21334446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low risk of Clostridium difficile infections in hospitalized patients with inflammatory bowel disease in a German tertiary referral center.
    Ott C; Girlich C; Klebl F; Plentz A; Iesalnieks I; Schölmerich J; Obermeier F
    Digestion; 2011; 84(3):187-92. PubMed ID: 21646782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructure of Clostridium difficile colonies.
    Lipovsek S; Leitinger G; Rupnik M
    Anaerobe; 2013 Dec; 24():66-70. PubMed ID: 24120350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology of Clostridium difficile: implications for epidemiology and diagnosis.
    Carroll KC; Bartlett JG
    Annu Rev Microbiol; 2011; 65():501-21. PubMed ID: 21682645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium difficile in children: colonisation and disease.
    Enoch DA; Butler MJ; Pai S; Aliyu SH; Karas JA
    J Infect; 2011 Aug; 63(2):105-13. PubMed ID: 21664931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.